Those who purchased NuVasive, Inc. (NASDAQ: NUVA) in 2008 or earlier and continue to hold any ... and other legal …
NuVasive, Inc. (NUVA - Free Report) is expected to report first-quarter ... multiple reflects a relatively gloomy picture. The stock’s valuation looks stretched when compared to its industry. NuVasive currently trades at a P/E ratio of 34.50, …
NuVasive Inc. (NUVA) traded on unusually high volume on Apr. 21, as the stock lost 0.9% to close at $75.02. On the day, NuVasive Inc. saw 711,563 shares trade hands on 5,235 trades. Considering that the stock averages only a daily …
NuVasive (NASDAQ:NUVA) opened at 71.70 on Friday. The company’s 50-day moving average price is $74.36 and its 200-day moving average price is $68.70. The stock has a market cap of $3.63 billion, a P/E ratio of 103.91 and a beta of …
Up 11.43% in the year to date, and 61% in the past twelve months, active in M&A, with a market capitalisation of $3.795bn. Positive news around NuVasive's stock includes the fact that the company's quarterly EPS and sales figures …
He writes that three medical trade shows, along with a number of notable companies—including Edwards, Stryker (SYK), NuVasive (NUVA), and Spectranetics (SPNC)–reporting earnings should serve as catalyst for the sector next week, …
SAN DIEGO, April 19, 2017 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the launch …
Investors in Nuvasive Inc (Symbol: NUVA) saw new options become available this week, for the January 2017 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the NUVA options chain for the new January …
NASDAQ5mon
This suggests that analysts have very recently bumped up their estimates for NUVA, giving the stock a Zacks Earnings ESP of 2.44% heading into earnings season. NUVASIVE INC Price and EPS Surprise NUVASIVE INC Price and EPS …